This project builds on recent work reporting tick transmission of relapsing fever spirochetes and genome sequencing of both the pathogen and tick vector. We have utilized both next generation and ...
FOXO Technologies (FOXO) has signed a non-binding agreement to acquire Vector Biosource. Vector is an information and biospecimen sourcing ...
2 天
MyChesCo on MSNChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing ...
AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果